Major Depressive Disorder: Assessment, Treatment Evidence and Safety

Direct answer: Major depression is persistent depressed mood or loss of interest with other symptoms and meaningful impairment. It differs from a passing low mood and is not always caused by an identifiable stressor. Assessment should consider bipolar episodes, physical illness, substances and suicide risk before choosing care. Confidence is high in the need for appropriate assessment and safety review, and moderate in this selected summary of clinical care pathways. A supplement substitute is not independently established here. Recommendations are not relabeled as clean, independently replicated trial results (NIMH depression).

Table of contents

• Evidence summary
• What it is
• How it works
• The evidence-based treatments
• Supplement and lifestyle evidence
• What works and what does not
• Risks and side effects
• Important interactions
• Who should avoid unsupervised treatment
• Dosage and how to take
• Animal and in-vitro evidence
• Funding and source roles
• Frequently asked questions
• Sources and funding notes

Evidence summary

The source roles below are deliberately different. A health-agency explanation can support definitions and a clinical guideline can describe recommended care; neither automatically clears the funding of its supporting trials. This selected review does not provide a newly pooled treatment-effect estimate.

What it is

Depression can affect energy, concentration, sleep, appetite, movement and the ability to carry out everyday tasks. Irritability may be prominent, and some people notice pain or digestive complaints. NIMH describes a depressive episode with depressed mood or loss of interest most of the time for at least two weeks, alongside other symptoms. This timing is part of assessment, not a reason to wait in a crisis or a stand-alone diagnostic test. The course may involve a single or recurrent episode. Seasonal, psychotic, perinatal, melancholic or atypical features can matter clinically; they should not be inferred from one symptom. Anxiety can coexist without explaining the whole illness. (NIMH depression).

How it works

Genetic, biological, environmental and psychological influences interact. Stressful events can contribute, but depression can occur without an obvious life event. There is no single established cause, and a response to an antidepressant does not prove a simple chemical deficiency. Medical conditions and some medicines can produce or worsen depressive symptoms. A history of periods with markedly increased energy, reduced need for sleep or unusual risk-taking matters because bipolar depression has a different care pathway. During the menopause transition, changes in mood also merit assessment rather than automatic attribution to hormones alone. (NIMH depression).

The evidence-based treatments

NIMH describes psychotherapy, antidepressants and, for selected people, brain stimulation. NICE organizes adult care around severity, functioning, preferences, past response and other needs. Psychological approaches include CBT, behavioural activation and interpersonal therapy. Less severe symptoms do not automatically require medicine, while severe illness may need combined or specialist care. Review should ask whether a chosen treatment was actually delivered and tolerated, not merely whether it was listed in a record. ECT may be considered when a rapid response is needed or other approaches have failed; it requires informed specialist assessment and carries risks including memory effects and anaesthesia-related considerations. This guide reports the care pathways without asserting a financially cleared comparative effect size for every intervention. (NIMH depression; NICE adult depression guidance).

Supplement and lifestyle evidence

Regular sleep, a balanced diet, manageable activity and support can help a person participate in care. They should be adapted to health and circumstances. General wellbeing benefits do not prove that a routine treats this particular disorder or prevents recurrence. Evidence about stress in healthy volunteers cannot automatically answer a question about a diagnosed clinical condition (NIMH psychotherapies).

This guide establishes no independent supplement replacement for condition-specific assessment and treatment. The public complementary-health summary is used to identify limits and precautions, not to certify the independence of every underlying product study. A manufacturer-funded positive trial, a gift of study material, or an author’s relevant sales interest would exclude that outcome from the strict independent verdict. Unknown finances would remain unknown, rather than be called clean (NCCIH depression).

What works and what does not

Measure both symptom change and return to meaningful functioning. Recurrence prevention is a separate task from getting through an episode. Before reducing care, discuss ongoing risks, warning signs and a follow-up plan. Feeling better briefly is not the same as establishing sustained recovery.

Risks and side effects

Seek urgent help for suicidal intent, inability to eat or drink adequately, psychosis, severe agitation or inability to remain safe. New confusion or severe physical symptoms require medical assessment. A history of depression must not be used to dismiss another illness.

Thoughts of suicide, a plan to act, or inability to keep yourself or another person safe need urgent help. In an immediate danger, contact local emergency services; in the United States, 988 provides crisis support and 911 is for life-threatening emergencies. These numbers are jurisdiction-specific. Tell a trusted person and obtain help rather than relying on an article or supplement. If someone is at immediate risk, do not leave them alone while arranging safe assistance (NIMH suicide warning signs).

Medicines can cause unwanted effects and some require monitoring or a gradual stopping plan. New agitation, marked behavioural change or worsening suicidal thoughts should be reported promptly, particularly around starting or changing an antidepressant. A difficult therapy session should be discussed too; agreed pacing and safety matter (NIMH mental health medications).

Important interactions

Give the clinician or pharmacist the complete list of prescription medicines, non-prescription products, alcohol and recreational substances. Some products act on overlapping systems. NIMH warns that combining serotonergic medicines with certain other drugs or St John’s wort can cause serotonin syndrome. Sedating products can compound impairment. “Natural” does not establish compatibility, and a supplement sold for mood may affect another treatment. Review the actual product and ingredients, rather than assuming a general calming label is enough (NIMH mental health medications).

Who should avoid unsupervised treatment

Children and adolescents, pregnant or breastfeeding patients, older adults with several medicines, and people with complex medical or psychiatric histories need tailored decisions. Anyone with crisis symptoms should avoid substituting self-treatment for urgent assessment. Do not borrow another person’s medicine, copy an adult plan for a child, or use a forum recommendation as an instruction to stop prescribed care. Coexisting conditions may change the risk–benefit balance and the appropriate provider (NIMH mental health medications).

Dosage and how to take

No personal medicine dose, supplement regimen or exposure schedule is provided. Choice, timing, duration, monitoring and stopping depend on the diagnosis, age, other conditions and local instructions. A trial regimen describes what researchers studied, not what every reader should take. Ask the prescriber what benefit to expect, which adverse effects need contact, and how changes will be reviewed. Do not abruptly stop a prescribed medicine without an appropriate clinical plan (NIMH mental health medications).

Animal and in-vitro evidence

Changes in stress hormones, neurotransmitters or behaviour in cells or animals are clues to mechanisms. They cannot establish clinical recovery, functional improvement or safety in a person with this condition. Nor does laboratory activity identify the right human product, formulation or dose. This article excludes animal and cell findings from human efficacy conclusions. Mechanistic plausibility is kept separate from the clinical guidance summarized above.

Funding and source roles

Tier describes financial independence; the letter grade describes credibility for the stated use, not treatment potency. The source mix is concentrated in US and UK institutions, with international sources where indicated. Public funding is checked but does not erase individual or trial-level ties. Medicine, device, therapy, app and supplement providers may earn revenue from care; clinicians and institutions also have professional and service incentives. Those interests do not establish misconduct or a payment to this article.

Frequently asked questions

Is depression simply stress?

No. Stress can contribute, but depression has interacting causes and can occur without a clear stressor.

Does a two-week threshold mean I should wait for help?

No. A crisis, severe impairment or safety concern needs prompt help regardless of duration.

Can episodes return?

Yes. Some people have recurrent episodes. Relapse prevention and review should be discussed even after improvement.

Sources and funding notes

Original source pages were opened for this review, including recommendation text where a guideline is cited. The institution-level funding routes were checked; page-level contributors, guideline declarations and the full financial chain of supporting studies are not all cleared. Public recommendations are therefore reported as guidance, and no drug, device or supplement is assigned an independently verified effect size. Source dates vary and some pages predate the review. This is an educational, selected review rather than an exhaustive systematic search or personal medical advice.

• NIMH depression — Revised 2024
• NICE adult depression guidance — Exact source review date not established
• NIMH brain stimulation — Last Reviewed: March 2024
• NIMH psychotherapies — Last Reviewed: February 2024
• NIMH mental health medications — Last Reviewed: December 2023
• NIMH suicide warning signs — Revised 2023
• NCCIH depression — Last Updated: February 2020

Last reviewed: October 4, 2026.